12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Longboard Pharmaceuticals (NASDAQ:LBPH) shares moved upwards by 200.7% to $18.13 during Tuesday’s regular session. The company’s market…
Dow Turns Higher; Anavex Life Sciences Shares Plunge
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday.
The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500 also fell, dropping, 0.45% to 4,748.51.
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.
“A Single Drug And Multiple Study Failures Leave Anavex With Nothing But Cash” – StatNews
https://www.statnews.com/2024/01/02/anavex-rett-study-failure/It took Anavex Life Sciences seven months to finally acknowledge the failure of a late-stage clinical trial in Rett Syndrome.The negative study outcome was
Dow Down 100 Points; US Manufacturing PMI Falls In December
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ fell 1.35% to 14,808.88. The S&P 500 also fell, dropping, 0.72% to 4,735.41.
Why Clinical Stage Biopharmaceutical Company Anavex Shares Are Tanking Today
Anavex Life Sciences Corp. (NASDAQ: AVXL) shares are trading lower in the premarket session on Tuesday after the company provided an
Anavex Life Sciences Unveils Encouraging Phase 2/3 Trial Results for Rett Syndrome Treatment; Co-Primary Endpoint, The Clinical Global Impression, Was Not Met.
Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and
Crude Oil Falls; RedHill Biopharma Shares Spike Higher
U.S. stocks traded mixed toward the end of trading on Monday.
The Dow traded down 0.13% to 35,344.56 while the NASDAQ rose 0.11% to 14,266.69. The S&P 500 also fell, dropping, 0.08% to 4,555.47.
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
Nasdaq Moves Higher; US New Home Sales Fall In October
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Monday.
The Dow traded down 0.23% to 35,310.40 while the NASDAQ rose 0.21% to 14,280.12. The S&P 500 also fell, dropping, 0.07% to 4,556.10.